DarioHealth
DRIO
12 hedge funds and large institutions have $1.85M invested in DarioHealth in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 11 closing their positions.
8.3% less ownership
Funds ownership: 20.92% → 12.62% (-8.3%)
37% less funds holding
Funds holding: 19 → 12 (-7)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
64% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 11
91% less capital inflows, than outflows
Capital inflows: $105K | Capital outflows: $1.21M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$72K |
| 2 |
Rockefeller Capital Management
New York
|
+$27.6K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.21K |
| 4 |
Nantahala Capital Management
New Canaan,
Connecticut
|
+$110 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Meitav Investment House
Bene-Beraq,
Israel
|
-$718K |
| 2 |
Perkins Capital Management
Wayzata,
Minnesota
|
-$327K |
| 3 |
Verition Fund Management
Greenwich,
Connecticut
|
-$72K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$33K |
| 5 |
Bard Associates
Chicago,
Illinois
|
-$23K |
DRIO Hedge Fund Activity: Q4 2019 in Review
12 of the 5,094 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q4 2019, worth a combined $1.85M — down 34% from $2.81M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of DRIO and 4 opened new positions — a net loss of 7 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $72K. The largest seller was Meitav Investment House, exiting entirely with an estimated $718K sold.
- 12 institutional investors held DarioHealth (DRIO) as of Q4 2019, down from 19 in Q3 2019.
- Funds reported $1.85M of DarioHealth stock for Q4 2019, down 34% quarter-over-quarter.
- 4 funds opened new DarioHealth positions in Q4 2019 and 11 closed out, a net change of -7 holders.
- The largest DarioHealth buyer in Q4 2019 was Geode Capital Management, an estimated $72K added.
- The largest DarioHealth seller in Q4 2019 was Meitav Investment House, an estimated $718K sold.
Based on aggregated 13F filings for Q4 2019.